Exploitation of yeast as a model system for studying gene regulation by nuclear receptors (NRs)
===============================================================================================

Nuclear receptor (NR) mediated gene activation or repression is regulated by the cellular context of transcriptional coactivators and corepressors (CoRs) \[[@r3]; [@r8]; [@r16]\]. Due to the complexity of endogenous NR coregulators in mammalian cells it is difficult to determine the precise mechanisms by which NR coactivators and corepressors function.

The budding yeast *Saccharomyces cerevisiae* contains the conserved eukaryotic general transcriptional apparatus and chromatin remodeling enzymes, but is devoid of nuclear receptors and their coregulators (see \[[@r1]; [@r18]; [@r27]\] and references therein). In this yeast model system it becomes possible to measure qualitatively and quantitatively the functions of exogenous cofactors by reconstituting desired combinations of factors in isolation from the bewildering effects of a myriad of endogenous competing factors.

Transcriptional coactivation by factors binding to unliganded NRs
=================================================================

Our previous studies have proved that two types of human thyroid hormone receptor (hTR) coactivation pathways can be reconstituted in the yeast *Saccharomyces cerevisiae*. Firstly, p160 proteins, such as GRIP1 and SRC1, which contain LXXLL motifs necessary for hormone dependent interaction with the TR \[[@r11]; [@r26]\], require thyroid hormone (TH) and the SAGA adaptor protein complex to function \[[@r1]\]. This pathway is akin to TR coactivation pathways that have been extensively studied in mammalian systems \[[@r3]; [@r8]\] and functions through the intrinsic acetyltransferase activity of the SAGA adaptor complex \[[@r1]\]. Secondly, human adenovirus type 5 early region 1A (E1A) protein behaves as a TH independent TR coactivator in yeast and does not require GCN5 or other components of SAGA \[[@r18]\]. Interestingly, coactivation of TR dependent transcription by E1A is lost upon addition of hormone through a ligand induced loss of E1A-TR interaction \[[@r18]\].

Hormone-dependent loss of E1A-TR interaction is reminiscent of TR interactions with nuclear receptor corepressors such as N-CoR and SMRT, which interact with unliganded TR and with other NRs in the absence of hormone or in the presence of antagonists \[[@r3]; [@r8]\]. The corepressors contain NR interacting domains that share a core consensus motif: ΦXXΦΦ (where Φ is a hydrophobic residue and X is any amino acid) that comprise part of the extended consensus LXXI/HIXXXI/L CoRNR box motif (CBM) \[[@r13]\]. These motifs are believed to encode an extended amphipathic helix which contacts the same hydrophobic pocket that binds LXXLL motifs, but is not dependent on the charge clamp and the AF2 helix \[[@r13]; [@r23]\]. This configuration has been confirmed in an X-ray crystal structure of peroxisome proliferator activated receptor α in complex with an antagonist and a SMRT CBM peptide \[[@r28]\]. Inspection of E1A identified a short sequence (LDQLIEEVL amino acids 20-28) that strongly resembles a CBM and this was shown to be necessary for TR binding and coactivation, and to bind the same TR surface as corepressors \[[@r17]; [@r18]\]. Thus, a viral protein has co-opted a cellular protein interaction motif to target the unliganded TR. Although E1A binding to unliganded TR mimics that of corepressors, the end result is to confer constitutive coactivation function.

The interaction of E1A with TR in the absence of TH exemplifies the economical nature of adenovirus E1A to stoichometrically affect target protein function \[[@r7]\]. Clearly, if the purpose of the interaction of E1A with the unliganded TR is to activate transcription, there is no need for E1A to bind the TR in the presence of hormone and duplicate the function of existing cellular coactivators. This is highly reminiscent of the interaction of E1A with pRb, which regulates exit from the G1 phase of the cell cycle. In this case, E1A binds the hypophosphorylated form of pRb, which is actively involved in blocking G1 exit, but does not interact with inactive hyperphosphorylated forms of pRb \[[@r19]\]. Presumably, the frugality of targeting only those cellular proteins actively engaged in some activity preserves adequate levels of unbound E1A to serve all necessary cellular targets. However, the exact role of the interaction of the E1A protein with the TR is not clear. Inspection of the human adenovirus 5 genome failed to identify any consensus direct repeat TREs, but a number of consensus half sites are present. It remains to be determined if the TR can function through these half sites and whether the E1A proteins can influence any such activity, but it is tempting to speculate that they may play a role in controlling viral transcription and or replication in some fashion.

Given similarities between nuclear hormone receptors, it is also possible that E1A could engage in functionally important interactions with corepressor binding domains of other members of this family of transcription factors. Nevertheless, there is precedent for a role of thyroid hormone in regulating viral life cycle, as simian virus 40, human immunodeficiency virus type 1 and herpes simplex virus all contain functional TREs that control viral gene transcription \[[@r4]; [@r5]; [@r21]; [@r30]\].

These studies on the viral E1A protein also culminated in the novel observation that a nuclear receptor corepressor splice variant (N-CoR~I~) or a C-terminal fragment of N-CoR (N-CoR~C~) also act as hTR coactivators that bind in the repressor mode \[[@r17]\]. Both N-CoR~I~ and N-CoR~C~ lack the autonomous N-terminal repression domain found in the well characterized full length form of N-CoR. In the absence of the N-terminal domain, a paradoxical constitutive coactivation function can be observed which is dependent upon binding to hTR in a corepressor mode \[[@r17]\].

Mechanism of ligand independent transcriptional activation of NRs
=================================================================

N-CoR~I~/N-CoR~C~ or E1A thus act as novel constitutive coactivators (CCs) through the interaction of their CBMs with TR in the absence of TH \[[@r17]\]. Although, this mechanism appears entirely different from that of TH dependent coactivators (DCs), such as GRIP1 or SRC1 \[[@r1]; [@r18]\], both types of coactivators nevertheless enhance transcription of their target genes. To further explore the mechanisms by which N-CoR~I~/N-CoR~C~ function as activators, we constructed deletion mutants and determined that CBM1 is much more important than CBM2 and CBM3 for coactivation ([Figure 1](#fig1){ref-type="fig"}). If CBM1 was deleted, more than 90% of activity was lost. We also determined that CBM1 contains an intrinsic activation function using yeast one hybrid analysis (data not shown). Future studies will delimit the boundaries of this activation function and identify its target.

Although full-length N-CoR (FL-N-CoR) acts as a TR corepressor, N-CoR~I~/N-CoR~C~ function as coactivators that bind and activate unliganded TR in a yeast coexpression system. This likely occurs because these splice variants of N-CoR lack the intrinsic N-CoR repressor domain and harbor a hitherto unrecognized coactivator function that lies in the vicinity of CBM1. When a p160 coactivator is coexpressed in a yeast model system \[[@r1]; [@r27]\] or is endogenously present in a mammalian cell, TH induces hormone dependent coactivation (DC; [Figure 2](#fig2){ref-type="fig"}, left panel). In contrast, when a p160 coactivator is either not present or expressed at a relatively low level, TH induces a hormone dependent repression (i.e. negative regulation) on the constitutive unliganded coactivation of N-CoR~I~ (CC; [Figure 2](#fig2){ref-type="fig"}, right panel).

It must be acknowledged that experimental evidence for the physiological relevance of ligand independent activation by N-CoR~I~ in mammalian cells is lacking. However, splice variants devoid of N-terminal repressor domains have been isolated in mammalian cells for N-CoR~I~ \[[@r12]\] as well as s-SMRT \[[@r2]; [@r20]\] and TRAC-1 \[[@r24]\]. Moreover, these splice variants have been observed to not only be devoid of repressor function but may also have a dominant-negative inhibitory effect on corepressor function \[[@r2]; [@r12]; [@r24]\] and thereby serve as "anti-corepressors". Thus, it remains a possibility that ratio differences in the cellular context of corepressor FL compared to their splice variants may result in either an overall anti-corepressor or perhaps a predominant coactivator influence on TR regulated genes.

Intriguingly, there is increasing recognition that splice variants of N-CoR and SMRT corepressors may be adapted and tailored by alternative mRNA splicing to different cells and to different developmental stages as a mechanism for regulating metazoan gene expression (see \[[@r9]\] and references therein). Moreover, differences in the expression of corepressors in different tissues and at various times of development suggest that organisms may adapt to their corepressor repertoire for distinct biological purposes \[[@r14]\]. Since a number of alternatively spliced variants have been shown to differ in their abundance at different times of development or in different tissues \[[@r10]; [@r15]; [@r25]\], further studies will be required to fully understand the biological properties of such sequences. It is likely that modules within N-CoR and SMRT regulate the repression or activation of target genes by recruiting domain specific transcriptional regulators (see \[[@r9]\] and references therein). Although the characterization of such regulators is still in its infancy, alternative splicing events could represent a mechanism by which cells can modulate varying degrees of corepression or coactivation of target genes.

It is possible that there are other mechanisms which could alter the ratio of full-length corepressors and their splice variants in mammalian cells. FL-N-CoR is targeted for proteasomal degradation by interaction with the mSiah2 ubiquitin ligase, which binds the N-terminal 160 amino acid residues \[[@r29]\]. As this N-terminal region is absent in N-CoR~I~, mSiah2 should preferentially degrade FL-N-CoR. This could alter the ratio of FL-N-CoR to N-CoR~I~ and potentially influence gene expression. mSiah2 expression is known to be cell-type specific \[[@r29]\]. Interestingly, estrogen up-regulates mSiah2 expression leading to the subsequent degradation of FL-N-CoR \[[@r6]\], suggesting the presence of a complex feedback pathway that could come into play under certain conditions. Future studies should focus on the identification and characterization of genes essential for CC or DC mediated gene activation by NRs. It is likely that some of these genes will play a role in regulating CoR function, whether by affecting their transcription, splicing, degradation or post-translational modifications in normal, pathogenically infected or disease stage cellular contexts \[[@r22]\].
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![Analysis of the importance of the various CBMs for N-CoR~C~ coactivation in hTR dependent gene activation in yeast.\
Left Side: A schematic depiction of the portions of N-CoR~C~ used in this study, which were fused to the GAL4-DNA binding domain. The amino acid residues present in each fragment are as indicated, as are the positions of the CBMs. Right Side: β-gal assays were performed with a yeast strain containing a β-galactosidase reporter gene regulated by single copy of the chicken lysozyme (F2) TRE and expressing hTRβ1, the indicated portions of N-CoR~C~ or empty vector. Cultures were treated with either vehicle (grey bars) or 10^-6^ M Triac (black bars). β-gal activity is expressed as Miller units per mg of protein. Data shown were pooled from three independent experiments and calculated as mean ± SE. Assay conditions as described previously \[Meng et al., 2005; Walfish et al., 1997\].](nrs04022.f1){#fig1}

![Schematic model in yeast of transcriptional regulation by corepressor or coactivator regulators.\
Left Side: The transcriptional response of FL-N-CoR and a p160 coactivator in the absence and presence of TH. Addition of TH leads to hormone dependent coactivation (DC). Right Side: The constitutive coactivation (CC) of a natural splice variant N-CoR~I~ in the absence and presence of TH.](nrs04022.f2){#fig2}
